IGF1 and mood disorder: Therefore, the increase in systemic IGF-1 levels observed in patients with mood disorders may be a compensatory mechanism that enhances the hypothalamic-pituitary-growth promotion axis in response to inadequate brain IGF-1 concentrations (11).